EN
HI
Summary
As of 8 Sep, 2026, Cohance Lifesciences stock price is ₹453.7. During the trading session, the stock has moved between an intraday low of ₹448.10 and an intraday high of ₹460.50. Over the last 52 weeks, Cohance Lifesciences has traded between ₹266.70 and ₹1038.90.
The stock has recorded a trading volume of 11,01,718 shares, with a market capitalization of ₹382567140. Its Average Traded Price (ATP) is ₹452.63, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹453.70.
Cohance Lifesciences has an upper circuit limit of ₹539.45 and a lower circuit limit of ₹359.65. The total value traded stands at ₹49.87 CR, and the delivery percentage for the day is 37.17%.
The stock is currently traded with a market lot size of 1. Cohance Lifesciences also offers a dividend yield of 0%.
Cohance Lifesciences share price chart
Cohance Lifesciences Share Key Metrics
Volume
11.02 L
Market Cap
17198.31 CR
LTQ@LTP
1@453.70
ATP
452.63
Var Margin
22.75 %
Circuit Range
359.65-539.45
Delivery %
37.17 %
Value
49.87 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Fundamentals
P/E Ratio
161.86
P/B Ratio
4.47
Div. Yield
0
Sector P/E
41.66
Sector P/B
3.6
Sec. Div. Yield
0.5
Cohance Lifesciences Resistance and Support
Pivot 450.42
Resistance
First Resistance
457.34
Second Resistance
465.12
Third Resistance
472.04
Support
First Support
442.64
Second Support
435.72
Third Support
427.94
Cohance Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 08 2026 | 451.8 | 453.7 | 0.93% | 460.5 | 448.1 |
| Mon Sep 07 2026 | 450 | 449.54 | -1.55% | 458.2 | 443.5 |
| Fri Sep 04 2026 | 463.29 | 456.6 | -0.92% | 470 | 453.6 |
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Completion Of USFDA Inspection
Cohance Lifesciences' formulation plant in Shamshabad was inspected by the USFDA from August 27 to September 4, 2026. The inspection concluded with the issuance of a Form FDA 483 with four observations, and the company has initiated corrective actions.
Sep 05 2026 00:29:48
Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cohance Lifesciences invests $18 million in NJ Bio and Aruka Bio to advance its Antibody-drug Conjugate strategy. This involves increasing its common-equity ownership in NJ Bio to 67.3% and acquiring controlling interest in Aruka Bio, with completion expected by end of September 2026.
Sep 03 2026 20:10:22
Read More
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Shilpa Medicare Ltd.
956.55
17.05 (1.81%)
Eris Lifesciences Ltd.
1319.00
-5.30 (0.40%)
Onesource Specialty Pharma Ltd.
1575.20
22.90 (1.48%)
Poly Medicure Ltd.
1727.90
26.80 (1.58%)
Dr. Agarwal's Health Care Ltd.
520.50
2.25 (0.43%)
Alembic Pharmaceuticals Ltd.
800.50
0.95 (0.12%)
Vijaya Diagnostic Centre Ltd.
1503.50
6.00 (0.40%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 453.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 161.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.47. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 41.66 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 17198.31 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1038.90 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
